BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32346444)

  • 1. Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway.
    Cheng H; Jiang X; Zhang Q; Ma J; Cheng R; Yong H; Shi H; Zhou X; Ge L; Gao G
    Exp Ther Med; 2020 Jun; 19(6):3798-3804. PubMed ID: 32346444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway.
    Zhou J; Xia L; Zhang Y
    Pathol Res Pract; 2019 Dec; 215(12):152707. PubMed ID: 31727500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K/Akt/mTOR signaling pathway.
    Ge X; Zhou G
    Am J Transl Res; 2021; 13(6):6330-6341. PubMed ID: 34306372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway.
    Tan X; Gong L; Li X; Zhang X; Sun J; Luo X; Wang Q; Chen J; Xie L; Han S
    Biomed Pharmacother; 2021 Nov; 143():112174. PubMed ID: 34560542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 6. HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway.
    Wang H; Chen Y; Yuan Q; Chen L; Dai P; Li X
    Front Oncol; 2022; 12():1053510. PubMed ID: 36568155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
    Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
    Eur J Pharmacol; 2019 Sep; 858():172477. PubMed ID: 31228450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways.
    Yang H; Liu JX; Shang HX; Lin S; Zhao JY; Lin JM
    World J Gastrointest Oncol; 2019 May; 11(5):377-392. PubMed ID: 31139308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 12. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells.
    Raha S; Yumnam S; Hong GE; Lee HJ; Saralamma VV; Park HS; Heo JD; Lee SJ; Kim EH; Kim JA; Kim GS
    Int J Oncol; 2015 Sep; 47(3):1061-9. PubMed ID: 26201693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
    Wei H; Dong C; Shen Z
    Neoplasma; 2020 Jul; 67(4):889-897. PubMed ID: 32386481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
    Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
    J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 19. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
    Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.
    Zhu W; Wu C; Liu Z; Zhao S; Cheng X; Huang J
    Cancer Cell Int; 2024 Jun; 24(1):201. PubMed ID: 38844922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.